Academic Commercialization Assessment Agent
An evidence-constrained agent that assesses the commercialization potential of research topics: deterministic retrieval, a six-stage LLM workflow, and an auditable, cited scorecard.
- Source repo
- shuxiachai/academic-commercialization-agent
- Stars
- ★ 812
- Last updated
- today
- License
- MIT
- Primary language
- Python
- FA score
- 84/100 · Good
At a glance
- How it runs
- Works with
- Universal · cross-platformOpenAI API · Claude API
- Cost
- Free software; you pay for model usage
- Setup effort
- Medium · a few setup steps
- You'll need
- Typical use
- A tech-transfer officer with a paper or topic direction needs a cited preliminary TRL and market-signal read before pursuing engagement.
- Not a fit if
- Teams needing multi-replica or distributed-queue scaling: one replica / one Uvicorn worker only
- Users needing technical, legal, investment or FTO due diligence: reports are triage only
- Website
- academic-agent.cc ↗ set on GitHub
- Maintenance
- Commits in the last 30 dayslast commit 2026-11-12latest release v2.1.0 (2026-10-17)+0.6 ★/day over 7 days
- Source review
- 84/100 · Good
What does this agent do, and when should you use it?
This open-source project (GitHub: shuxiachai/academic-commercialization-agent) assesses how far a research topic could travel toward commercialization, from technical maturity to market signals. It first runs deterministic retrieval over academic, patent and market sources, validates them into a frozen source registry, then runs three parallel evidence specialists (Academic, Patent, Market) followed by Writer, Reviewer and Scorer stages, with Scorer applying a deterministic weighted formula. The stack is Python, CrewAI, FastAPI and a build-free vanilla JavaScript client, exposed through browser, CLI and HTTP interfaces, deployable via Docker/Railway. Autonomy is deliberately limited: retrieval is not free-form, every claim carries citation IDs and reliability warnings, and reports export to Markdown or PDF. An interrupted run recovers as an immutable child from its longest validated checkpoint prefix. The authors publish a frozen baseline of 10 topics × 3 live repetitions and state plainly that reports support research triage only, not technical, legal or investment due diligence.
You submit a research topic or attach a paper PDF, optionally with Decision Context, which lets the system distinguish exploratory assessment from an actor-specific decision and whether a threshold is owner-approved. The flow is: deterministic retrieval (source-native clients plus Tavily/Serper web search) → URL/DOI checks, provenance tiers, deduplication and registered source IDs → frozen source registry → parallel Academic/Patent/Market specialists → Writer → bounded Reviewer corrections → Scorer with a deterministic weighted total. Output is a cited report with reliability warnings and a scorecard, exportable as Markdown or PDF and shareable via a run link. Run artifacts persist through content-addressed checkpoints; interrupted runs recover as immutable children. Deployment is a FastAPI application (one replica / one Uvicorn worker) with a browser UI, plus a CLI: uv run academic_agent --topic "solid-state batteries for electric vehicles". Run URLs carry 128 bits of randomness and act as read capabilities; mutation additionally requires an operator code or BYOK credentials.
- A tech-transfer officer with a paper or topic direction needs a cited preliminary TRL and market-signal read before pursuing engagement.
- A research group wants to cheaply triage out clearly immature topics before paying for commercial consulting on a translation grant application.
- A patent analyst wants academic literature, patents and market evidence aggregated in parallel as groundwork for deeper due diligence.
- An investor or incubator uses the Decision Context feature to anchor an assessment to a specific threshold and decision-maker rather than a generic feasibility report.
- An engineering team studying constrained multi-agent architectures can study its deterministic retrieval, frozen evidence registry, checkpoint recovery and published measurements.
Key setup facts
Pulled from the install and usage notes below. The project README has the current values.
- Environment variables
DASHSCOPE_API_KEYQWEN_MODELQWEN_API_BASETAVILY_API_KEY- Config files
.env.example.env- Runtime
- Python 3.11
How do you install or deploy this agent?
Requires Python 3.11 or 3.12 and uv: git clone https://github.com/shuxiachai/academic-commercialization-agent.git && cd academic-commercialization-agent && uv sync. Copy .env.example to .env and fill in credentials, e.g. for Qwen: LLM_PROVIDER=qwen, DASHSCOPE_API_KEY=your-key, QWEN_MODEL=qwen3.5-plus, QWEN_API_BASE=https://dashscope.aliyuncs.com/compatible-mode/v1, TAVILY_API_KEY=your-search-key. With multiple LLM keys present, set LLM_PROVIDER explicitly; otherwise auto-selection is DeepSeek → Qwen → Anthropic → OpenAI. Tavily takes precedence over Serper when both search keys are present. Before public deployment, configure access control, paid-operation limits, retention and persistent storage, and keep one application replica.
How do you use this agent?
Start locally with uv run uvicorn api.main:app --reload, open http://localhost:8000, then submit a topic or PDF and choose report language and scoring profile. CLI alternative: uv run academic_agent --topic "solid-state batteries for electric vehicles". You can also call the FastAPI HTTP endpoints documented in docs/operating-guide.md. Follow progress, citations and reliability warnings live; export Markdown or PDF and share the run link when done. If a run is interrupted, recover it as an immutable child using its longest validated checkpoint prefix and fresh credentials. Note that real analysis incurs provider usage; observed Qwen completions took 306–885 seconds, and the project promises no three-minute SLA.
What are this agent's strengths and limitations?
- Evidence constraint is a real differentiator: retrieval is deterministic, claims bind to registered source IDs, and the frozen baseline showed 0 unsupported numeric lines across 30 reports.
- Strong auditability and reliability engineering: content-addressed checkpoints, immutable recovery children, write-once terminal records, and 30/30 offline fault-injection recovery completions.
- Multi-provider support (Qwen/DeepSeek/OpenAI/Anthropic) plus BYOK mode avoids single-vendor lock-in; the browser client supports bring-your-own-key.
- Visible engineering quality: a 2071-test / 678-subtest baseline, CI across Linux/Windows × Python 3.11/3.12, an 85% coverage floor, Docker and zero-provider smoke tests.
- Honest evidence disclosure: a 90-cell topology ablation, reviewer utility study and user pilot are published with limitations, including failed gates.
- Cost and latency are nontrivial: real analysis consumes paid provider quota, single Qwen completions took 306–885 seconds, and PDF extraction is a paid operation too.
- Hard deployment constraints: in-memory ownership and file-backed quotas force one application replica / one Uvicorn worker — not a distributed queue — so scaling requires rework.
- Limited evidence coverage: TRL calibration was 26/30 with ranges adjusted after early observations, not independent held-out validation; the 10-topic benchmark excludes multilingual, short or non-technical topics.
- Weak product validation: a two-person target-user pilot retained DEFER with MAYBE on reuse, and the reviewer utility study missed its registered success rule — adoption value is unproven.
- Reports support research triage only, explicitly not technical, legal, regulatory, investment or FTO due diligence; valid citation IDs do not prove a source entails a claim.
How does this agent compare with similar options?
The project names no direct competitor. Its positioning differs from general autonomous agent frameworks (such as CrewAI, which this project uses as an orchestration library): the differentiation is deliberately compressed autonomy, with deterministic retrieval and auditable scoring replacing free-form tool calling; its Tool Calling extension remains in zero-call shadow mode and is not authorized for production.
Key facts side by side with the most closely related agents.
| Agent | Source review | Form / cost | Stars | Updated | Language | Full support on |
|---|---|---|---|---|---|---|
| Academic Commercialization Assessment Agent This agent | 84 · Good | Self-hosted serviceFree + model costs | ★ 812 | today | Python | OpenAI API · Claude API |
| AI Bank Statement Automation | 48 · Major gaps | CLIFree + model costs | ★ 634 | 5d ago | Jupyter Notebook | OpenAI API |
| Principia | 66 · Some gaps | CLIFree + model costs | ★ 1.1k | 1mo ago | Rich Text Format | — |
| TradingCodex | 66 · Some gaps | CLIFree + model costs | ★ 381 | 3mo ago | Python | Codex |
How does FollowAgents rate this agent?
Why each dimension lost points
The source and documentation describe retrieval, source validation, and a frozen registry before model stages, and explicitly distinguish a valid citation ID from actual claim support. Keys are handled per request or browser session; account keys are not stored by the server. Run URLs are read capabilities and sharing is cautioned. The concrete boundaries, quotas, backups, and recovery into a linked run support the relatively strong scores. Deductions reflect that a local deployment can start paid work without an access gate, ownerless BYOK links have no second identity check, run data is retained for a window, and the supplied evidence does not show per-request confirmation for external search.
README, code comments, and configuration agree on a single worker implementation, deterministic scoring, and staged pipeline; documentation also reports baseline and held-out limitations, an unresolved Windows CI observation, and the single-replica constraint. Dependencies have ranges and pins, with substantial CI and test documentation. Full marks are not justified because several dependencies remain open-ranged and the supplied dependency and availability evidence cannot cover all external model, search, and deployment services.
The intended users, research-topic/PDF inputs, report language, scoring configuration, CLI, web, and API paths are described. The product is bounded as research triage rather than due diligence and discloses limits in medical, market, language, and deployment coverage. The deduction reflects that visible trigger and configuration rules, while specific, still rely on environment variables and some defaults; broader scenario-specific adaptation controls are not shown.
A documentation map, repository layout, quick start, linked operating and deployment guides, sample reports, limitations, and MIT license are present. AGENTS.md is a contributor/code index rather than product runtime instructions. Deductions reflect the absence in the supplied files of a clear release changelog or user-facing migration path. The maintainer can be identified through author details, a security reporting path, and the main-branch support statement, but responsibility and response commitments remain limited.
Reports provide scorecards, sources, risks, reliability notices, and export, comparison, and recovery paths; deterministic scoring, paid-request receipts, and sample reports reduce friction. Deductions reflect the project's own disclosure that the decision-utility study missed its success rule, the user pilot was small, and independent utility is unvalidated. Real analysis consumes third-party model and search quota and duration depends on providers, so users must still judge value against cost.
Claims are linked to benchmark protocols, results, an evidence ledger, and stated limitations. Reported metrics are separated into distinct checks, and the materials distinguish intercepted scripts, model runs, inference, and source truth. README, result records, and test contracts corroborate some mechanisms. Deductions reflect that most quality figures remain repository-reported and cannot be independently verified from the supplied materials; a citation ID alone also does not establish semantic support.
- Use reports for research triage, not technical, legal, regulatory, investment, or freedom-to-operate due diligence. A valid citation ID does not establish that the source supports the claim.
- A real analysis consumes your model and search provider quota, and its duration and quality depend on external providers. The project discloses unresolved utility and market-scoring limitations.
- Sharing a run URL grants read access to anyone with the full link. Public deployments should configure access control, quotas, retention, and persistent storage, and should run as a single replica.
Recent releases
Latest entries from the project's GitHub Releases. Notes are quoted from upstream as written, not rewritten or tested by FollowAgents.
-
v2.1.0 v2.1.0 - Easier to try, safer to pay for
Release notes excerpt
Academic Commercialization Assessment Agent v2.1.0 Easier to try, safer to pay for, honest about market scores Version 2.1.0 collects seven weeks of work since v2.0.0: a keyless way to see finished reports, paid requests that survive refreshes and lost replies, a first production Tool Calling feature with tightly bounded scope, and clearer disclosure of what the market score can and cannot show. Reports remain decision support for research triage, not legal, regulatory, technical, or investment advice. Highlights Try it without keys …View on GitHub ↗ -
v2.0.0 v2.0.0 - Reliability-first production workflow
Release notes excerpt
Academic Commercialization Assessment Agent v2.0.0 Reliability-first production workflow Version 2.0.0 turns the original Gradio demonstration into a deployable, evidence-constrained decision-support system. A FastAPI service, build-free web client, CLI, and recovery path now observe the same persisted run artifacts. The release also adds measured evaluation, paid-operation controls, privacy-reduced tracing, and node-level crash recovery. This remains decision support rather than legal, regulatory, technical, or investment advice. Highlights Evidence before generation …View on GitHub ↗ -
Release notes excerpt
Academic Commercialization Assessment Agent — v1.0.0 First public release of a multi-agent system that turns any research paper or topic into a structured commercialization readiness report with verifiable citations. Features Multi-agent pipeline (6 agents, CrewAI) - Agent 1–3 run in parallel: Academic Literature Analysis, Patent Landscape, Market Intelligence - Agent 4: Report writing with inline citations [A1][P2][M3] and auto-retry guardrail - Agent 5: Quality review with 6 citation integrity rules …View on GitHub ↗
FAQ
How much does a run cost?
Which model providers are supported?
Can I use the report for investment or legal decisions?
What happens if a run is interrupted?
Can I scale horizontally to multiple instances?
Is Academic Commercialization Assessment Agent open source?
Is Academic Commercialization Assessment Agent safe to use?
Is Academic Commercialization Assessment Agent still maintained?
Who makes Academic Commercialization Assessment Agent?
What is Academic Commercialization Assessment Agent's official website?
Thanks — we use this to improve the page.